Share price nbrv
WebbEconomies.com provides you with Nabriva Therapeutics AG share price (NBRV) listed in the stock exchange, including the low, high, opening and closing price. In addition, we … Webb10 apr. 2024 · 10% least volatile stocks in US Market. 3.0%. Stable Share Price: NBRV is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 16% a …
Share price nbrv
Did you know?
WebbNBRV Long Price crossed SMA21 and SMA50 OBV> OBV34 WR buy signal Concern: 12/3/2024 Split 1:10, price 3.77 is strong resistance. Entry 1.2 Stop 0.9 Target1 2.3 Target2 3.4 Risk management is much more important than a good entry point. The max Risk of each plan should be less than 1% of an accoun Price crossed SMA21 and SMA50 OBV> … WebbFör 1 dag sedan · Stock Price Forecast. According to 6 stock analysts, the average 12-month stock price forecast for NBRV stock is $ 1.02 , which predicts a decrease of …
Webb9 apr. 2024 · NASDAQ:NBRV opened at $1.75 on Friday. The stock has a market cap of $53.62 million, a price-to-earnings ratio of -0.09 and a beta of 1.56. Nabriva Therapeutics has a one year low of $1.22 and a one year high of $10.25. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.40 and a current ratio of 2.20. Webbför 2 dagar sedan · This week, our team members took part in the first Volun-TEU event of 2024, being Clean Up Australia Day. Across three states, a number of volunteers…
Webb2 dec. 2024 · Nabriva Therapeutics’ ordinary shares will continue to trade on the Nasdaq Global Select Market under the symbol “NBRV” and the new CUSIP number for Nabriva … WebbFind real-time NBRV - Nabriva Therapeutics PLC stock quotes, company profile, news and forecasts from CNN Business. NBRV - Nabriva Therapeutics PLC Stock quote - …
WebbBased on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBRV is experiencing selling pressure, which indicates risk of future bearish movement.
WebbNabriva Therapeutics plc revenue breakdown overview. Nabriva Therapeutics plc revenue for the last year amounted to 35.01M USD, the most of which — 28.89M USD — came from its highest performing source at the moment, Novel Anti-infective Agents, the year earlier bringing 5.03M USD. dharsh fernando cardiologistWebbStock analysis for NewAge Inc (NBEV) including stock price, stock chart, company news, key statistics, fundamentals and company profile. d harris txWebb7 apr. 2024 · Needham & Company LLC reaffirmed a “buy” rating and issued a $120.00 target price on shares of Amazon.com in a ... NBRV) Stock Price Crosses Below 50 Day Moving Average of $1.70; ... dharsiwa raipur pin codeWebbNabriva Therapeutics (NBRV) has 2 splits in our Nabriva Therapeutics stock split history database. The first split for NBRV took place on December 03, 2024. This was a 1 for 10 … cif irecWebb27 mars 2024 · With Nabriva Therapeutics stock trading at $1.74 per share, the total value of Nabriva Therapeutics stock (market capitalization) is $53.31M. How much is Nabriva … cif iris chainsWebb6 sep. 2016 · Nabriva Therapeutics has actually seen rising estimates over the past one month and looks well positioned for a solid gain, but has been overlooked by investors. cif isavalWebbGet Nabriva Therapeutics AG (NBRV)'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house. cif inveryera